IndiaInfoline » Markets » BIOCON

Biocon Ltd - Share Price

BIOCON

Open

278.10

Prev. Close

278.40

Turnover (lac.)

18,311

Day's High

295.85

Day's Low

277.90

52 Week's High

323.50

52 Week's Low

211.05

Book Value

62

Face Value

5

Mkt Cap (Cr.)

34,914

P/E

114.98

EPS

2.53

Divi. Yield

0.17

Biocon LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Biocon LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd375.9528.8790,191.00468.760.732,920.8398.33
Dr Reddys Laboratories Ltd3,146.8019.8152,257.80521.700.643,032.20852.65
Divis Laboratories Ltd1,901.0539.7250,456.29360.730.841,390.49266.77
Cipla Ltd449.2015.4236,208.03282.220.672,821.92209.71
Torrent Pharmaceuticals Ltd2,077.0037.5935,148.69220.000.821,436.00323.64

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Biocon LtdSummary & Reports

Biocon Limited is Indias largest and fully-integrated, innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab), KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab), a first in class anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of development including Insulin Tregopil, ... More

Registered Office

20th KM Hosur Road Hebbagodi,Electronic City P O,Bangalore, Karnataka,560100

Tell. : +91-80-28082808
Website : http://www.biocon.com
Email : co.secretary@biocon.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

View

- <

Reco. Price

Apr 01,2020 08:17 AM

Target Price

Target Returns:

0.00%

Result Express

Biocon Ltd's Q3FY19 consolidated net profit rises 136.34% yoy to Rs217.20cr : Beats Estimates

Apr 04, 2020 03:26 AM

The company’s consolidated revenue stood at Rs1,540.80cr, up 45.65% yoy and 16.64% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    23 Jan 2020

    Annc. Date

    03 Jan 2020

    BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled o... More

  • Purpose

    Board Meeting

    Exp. Date

    23 Oct 2019

    Annc. Date

    03 Oct 2019

    BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled o... More